Tralokinumab for the Treatment of Adult Atopic Dermatitis in Special Populations
Our experience showed that tralokinumab is effective and safe in elderly patients and subjects affected by severe comorbidities.
Authors
- Maddalena Napolitano (ORCID: https://orcid.org/0000-0003-3309-8190)
- Stefano Dastoli (ORCID: https://orcid.org/0000-0002-4179-8261)
- Luca Potestio (ORCID: https://orcid.org/0000-0001-5940-0592)
- Cataldo Patruno (ORCID: https://orcid.org/0000-0001-8661-2822)
- Claudio Brescia (ORCID: https://orcid.org/0009-0007-5094-5052)
Institutions
- Magna Graecia University (IT)
- Federico II University Hospital (IT)
- University of Naples Federico II (IT)
Publication Details
- Journal
- Journal of Asthma and Allergy
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/jaa.s474411
- Citations
- 8
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.28